Biallelic mutations in DNAJC6 cause a complex, early-onset movement disorder with additional neurological and neuropsychiatric features.2-6 The movement disorder is mainly characterized by progressive childhood-onset parkinsonism-dystonia that responds poorly to standard medications used in the treatment of PD. This evidence concerns the gene DNAJC6 and Dystonia.